Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 949 000 KRW 1.06%
Market Cap: 67.5T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Samsung Biologics Co Ltd

Revenue
4.4T KRW
Cost of Revenue
-2.2T KRW
Gross Profit
2.2T KRW
Operating Expenses
-809B KRW
Operating Income
1.3T KRW
Other Expenses
-291.9B KRW
Net Income
1.1T KRW

Margins Comparison
Samsung Biologics Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Samsung Biologics Co Ltd
KRX:207940
67.5T KRW
49%
31%
24%
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
55%
14%
9%
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.9B USD
41%
17%
14%
US
Danaher Corp
NYSE:DHR
165.5B USD
60%
21%
18%
CH
Lonza Group AG
SIX:LONN
38.4B CHF
29%
13%
9%
US
Agilent Technologies Inc
NYSE:A
38.4B USD
55%
24%
20%
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD
35%
14%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD
59%
28%
21%
US
West Pharmaceutical Services Inc
NYSE:WST
23.9B USD
35%
20%
17%
CN
WuXi AppTec Co Ltd
SSE:603259
163.8B CNY
40%
27%
21%
US
Waters Corp
NYSE:WAT
22B USD
60%
29%
21%
Country KR
Market Cap 67.5T KRW
Gross Margin
49%
Operating Margin
31%
Net Margin
24%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 200.9B USD
Gross Margin
41%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 165.5B USD
Gross Margin
60%
Operating Margin
21%
Net Margin
18%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Operating Margin
13%
Net Margin
9%
Country US
Market Cap 38.4B USD
Gross Margin
55%
Operating Margin
24%
Net Margin
20%
Country US
Market Cap 36.2B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 26.8B USD
Gross Margin
59%
Operating Margin
28%
Net Margin
21%
Country US
Market Cap 23.9B USD
Gross Margin
35%
Operating Margin
20%
Net Margin
17%
Country CN
Market Cap 163.8B CNY
Gross Margin
40%
Operating Margin
27%
Net Margin
21%
Country US
Market Cap 22B USD
Gross Margin
60%
Operating Margin
29%
Net Margin
21%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Samsung Biologics Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Samsung Biologics Co Ltd
KRX:207940
67.5T KRW
10%
7%
11%
7%
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
3%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.9B USD
13%
6%
9%
7%
US
Danaher Corp
NYSE:DHR
165.5B USD
8%
5%
6%
5%
CH
Lonza Group AG
SIX:LONN
38.4B CHF
6%
3%
6%
5%
US
Agilent Technologies Inc
NYSE:A
38.4B USD
22%
11%
16%
14%
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD
22%
5%
11%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD
-611%
24%
49%
29%
US
West Pharmaceutical Services Inc
NYSE:WST
23.9B USD
18%
13%
18%
17%
CN
WuXi AppTec Co Ltd
SSE:603259
163.8B CNY
15%
11%
18%
17%
US
Waters Corp
NYSE:WAT
22B USD
52%
14%
23%
18%
Country KR
Market Cap 67.5T KRW
ROE
10%
ROA
7%
ROCE
11%
ROIC
7%
Country US
Market Cap 1.2T USD
ROE
3%
ROA
2%
ROCE
3%
ROIC
3%
Country US
Market Cap 200.9B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
7%
Country US
Market Cap 165.5B USD
ROE
8%
ROA
5%
ROCE
6%
ROIC
5%
Country CH
Market Cap 38.4B CHF
ROE
6%
ROA
3%
ROCE
6%
ROIC
5%
Country US
Market Cap 38.4B USD
ROE
22%
ROA
11%
ROCE
16%
ROIC
14%
Country US
Market Cap 36.2B USD
ROE
22%
ROA
5%
ROCE
11%
ROIC
9%
Country US
Market Cap 26.8B USD
ROE
-611%
ROA
24%
ROCE
49%
ROIC
29%
Country US
Market Cap 23.9B USD
ROE
18%
ROA
13%
ROCE
18%
ROIC
17%
Country CN
Market Cap 163.8B CNY
ROE
15%
ROA
11%
ROCE
18%
ROIC
17%
Country US
Market Cap 22B USD
ROE
52%
ROA
14%
ROCE
23%
ROIC
18%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top